Cardiac Function in Swimming-Induced Pulmonary Edema (SIPE)
NCT05391737 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-02-27
Summary
Acute or chronic cardiac dysfunction could be a contributing factor to swimming-induced pulmonary edema (SIPE). Knowledge on cardiac function in SIPE is limited and recommendations for cardiac evaluation of patients with SIPE are lacking. The present study was designed to assess cardiac function in patients with SIPE and in asymptomatic swimmers.
Conditions
- Swimming Induced Pulmonary Edema (SIPE)
- Pulmonary Edema
- Lung Diseases
- Heart Function Tests
Interventions
- DIAGNOSTIC_TEST
-
Echocardiography
Echocardiography after swimming (acute) and at rest (baseline)
- DIAGNOSTIC_TEST
-
Electrocardiogram (ECG)
Electrocardiogram (ECG) after swimming (acute) and at rest (baseline)
- DIAGNOSTIC_TEST
-
Cardiac biomarkers
high sensitive (hs)-Troponin I and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) after swimming (acute) and at rest (baseline)
Sponsors & Collaborators
-
Dalarna County Council, Sweden
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-06
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
Effects of Pentoxiphylline on Left Ventricular (LV) Systolic Function Indices and Circulating Biomarkers in Patients With Chronic Congestive Heart Failure (CHF)
NCT01337349 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
NCT00050076 ·Status: COMPLETED ·Phase: PHASE2
-
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
NCT05919342 ·Status: RECRUITING ·Phase: NA
-
Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients
NCT01377987 ·Status: COMPLETED ·Phase: NA
-
Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia
NCT00117234 ·Status: COMPLETED ·Phase: NA
-
The Effects of Ambrisentan on Exercise Capacity in Fontan Patients
NCT01971580 ·Status: COMPLETED ·Phase: PHASE4
-
Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)
NCT00729222 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease
NCT01971593 ·Status: TERMINATED ·Phase: PHASE4
-
Antiarrhythmic Effects of Spironolactone in Patients With ICDs
NCT04495712 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart Failure
NCT00517426 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction
NCT05139615 ·Status: TERMINATED ·Phase: PHASE2
-
Study of the Acute Effects of Triheptanoin in Heart Failure
NCT01787851 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
0.5M Na Lactate Solution in Acute Heart Failure (AHF)
NCT01981655 ·Status: COMPLETED ·Phase: PHASE2
-
Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
NCT00354328 ·Status: COMPLETED
-
Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions
NCT01235156 ·Status: UNKNOWN
-
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT06560762 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
NCT02814097 ·Status: COMPLETED ·Phase: PHASE2
-
Surfactant Derived Protocol in Heart Failure
NCT06896461 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Acute Heart Failure
NCT00537628 ·Status: COMPLETED
-
Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function
NCT06039072 ·Status: UNKNOWN
-
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT03254485 ·Status: COMPLETED ·Phase: PHASE2
-
Outcome and Safety of Intermittent Dobutamine Infusion at a Day-Care Center in Advanced Heart Failure Patients
NCT01930734 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT06122779 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction
NCT05045274 ·Status: UNKNOWN ·Phase: NA
-
Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion
NCT00247052 ·Status: COMPLETED ·Phase: PHASE4